SCHEMBL9920972

SCHEMBL9920972

CC(C)(C)c1cc2ccc3c(-c4ccc(-c5ccccc5)cc4)cc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)c4ccc(c1)c2c34

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HDAC4 P56524 1/20 0.34
PPARG P37231 4/20 0.34
HSD17B10 Q99714 1/20 0.34
PPARA Q07869 2/20 0.33
GPR84 Q9NQS5 1/20 0.32
KMT2A Q03164 1/20 0.32
AKR1C4 P17516 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
AKR1C1 Q04828 1/20 0.31
HPGD P15428 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920971 0.99 KDM4E (0.40) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL21234913 0.98 KDM4E (0.37) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL21234908 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL21234911 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920914 0.96 KDM4E (0.35) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920913 0.94 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920985 0.94 ALDH1A1 (0.39) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920828 0.93 ALDH1A1 (0.39) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920850 0.93 ALDH1A1 (0.35) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9920765 0.93 ALDH1A1 (0.37) KDM4EL3MBTL1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
EP-1942171-B1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES (JP) 2018-04-18 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
EP-2595208-A1 LIGHT EMITTING ELEMENT Toray Industries, Inc. (JP) 2013-05-22 EP disclosed
US-20130105787-A1 LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2013-05-02 US disclosed
US-20130105787-A1 LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2013-05-02 US disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 KDM4E 2433/4885L3MBTL1 283/4885ATM 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.